Inventor · disambiguated record
Jeffrey E. Settleman
Also filed as: SETTLEMAN JEFFREY · SETTLEMAN JEFFREY E
12 granted patents·7 pending applications·480 citations·filing 1994–2022
92Inventor score
Files withGEN HOSPITAL CORP4GENENTECH INC4MASSACHUSETTS GEN HOSPITAL3BELL DAPHNE WINIFRED2WYETH LLC2
Top patents by PatentIndex Score
19 records- 0198US7964349B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsGEN HOSPITAL CORP·Filed 2007·Granted Jun 21, 2011·92 cites·31 claims
- 0298US7294468B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsGEN HOSPITAL CORP·Filed 2005·Granted Nov 13, 2007·187 cites·8 claims
- 0396US8465916B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsBELL DAPHNE WINIFRED·Filed 2007·Granted Jun 18, 2013·85 cites·21 claims
- 0496US8105769B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsBELL DAPHNE WINIFRED·Filed 2007·Granted Jan 31, 2012·97 cites·4 claims
- 0589US9035036B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsGEN HOSPITAL CORP·Filed 2013·Granted May 19, 2015·8 cites·26 claims
- 0680US10596162B2Method for treating gefitinib resistant cancerWYETH LLC·Filed 2016·Granted Mar 24, 2020·3 cites·4 claims
- 0775US12006555B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsMASSACHUSETTS GEN HOSPITAL·Filed 2020·Granted Jun 11, 2024·0 cites·16 claims
- 0874US10603314B2Method for treating gefitinib resistant cancerHABER DANIEL A·Filed 2006·Granted Mar 31, 2020·3 cites·9 claims
- 0973US10669589B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsMASSACHUSETTS GEN HOSPITAL·Filed 2018·Granted Jun 2, 2020·0 cites·13 claims
- 1071US2023226039A1Method for treating gefitinib resistant cancerWYETH LLC·Filed 2022·Application pending·0 cites
- 1159US10000815B2Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatmentsMASSACHUSETTS GEN HOSPITAL·Filed 2015·Granted Jun 19, 2018·0 cites·32 claims
- 1252US2015125452A1Combination treatments comprising c-met antagonists and b-raf antagonistsGENENTECH INC·Filed 2014·Application pending·0 cites
- 1351US10953013B2Biomarkers of response to NAE inhibitorsMILLENNIUM PHARM INC·Filed 2016·Granted Mar 23, 2021·0 cites·12 claims
- 1450US2016143910A1Methods of treating cancer and preventing cancer drug resistanceARORA SHILPI·Filed 2014·Application pending·0 cites
- 1548US2013078252A1Combination treatments comprising c-met antagonists and b-raf antagonistsGENENTECH INC·Filed 2012·Application pending·0 cites
- 1641US2014243403A1Treating colorectal, pancreatic, and lung cancerSINGH ANURAG·Filed 2012·Application pending·0 cites
- 1737US2023190750A1Methods of treating and preventing cancer drug resistanceGENENTECH INC·Filed 2015·Application pending·0 cites
- 1834US2017204187A1Methods of treating and preventing cancer drug resistanceGENENTECH INC·Filed 2015·Application pending·0 cites
- 1930US5639651AGap-related gene, human IQGAP1GEN HOSPITAL CORP·Filed 1994·Granted Jun 17, 1997·5 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →